Skip to content
Recall Observatory FDA recall evidence

Drug product

BENZONATATE Capsules, USP, 200 mg, 100 Capsule Bottles, Rx only. Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA, Inc. NDC: 68382-248-01

D-0289-2015

September 24, 2014

Class III

Product summary

Firm
Zydus Pharmaceuticals USA Inc
Event
Event 69585
Status
Terminated
Classification
Class III
Quantity
63,648 Bottles
Official record key
drug-enforcement:D-0289-2015

Official wording

Reason: Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.

Code information: Lot #: MM8555, Expiry: 09/14; Lot #: MM6604, Expiry: 09/14; Lot #: MM8551, Expiry: 09/14; Lot #: MM8552, Expiry: 09/14; Lot #: MM8553, Expiry: 09/14; Lot #: MM8554, Expiry: 09/14.

Distribution pattern: US Nationwide including Puerto Rico

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    Foreign Capsules